RTX Corporation vs AstraZeneca PLC
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
RTX Corporation
$257.8B
์์ #55
AstraZeneca PLC
$266.0B
์์ #52
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- RTX Corporation์ด(๊ฐ) 2004๋ ๊น์ง AstraZeneca PLC์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- AstraZeneca PLC์ด(๊ฐ) 2005๋ ๊น์ง RTX Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- RTX Corporation์ด(๊ฐ) 2007๋ ๊น์ง AstraZeneca PLC์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- AstraZeneca PLC์ด(๊ฐ) 2008๋ ๊น์ง RTX Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- RTX Corporation์ด(๊ฐ) 2009๋ ๊น์ง AstraZeneca PLC์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- AstraZeneca PLC์ด(๊ฐ) 2014๋ ๊น์ง RTX Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- RTX Corporation์ด(๊ฐ) 2016๋ ๊น์ง AstraZeneca PLC์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- AstraZeneca PLC์ด(๊ฐ) 2018๋ ๊น์ง RTX Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | RTX Corporation | AstraZeneca PLC | ์ ๋ |
|---|---|---|---|
| 2026 | $257.8B | $266.0B | AstraZeneca PLC |
| 2025 | $245.1B | $282.2B | AstraZeneca PLC |
| 2024 | $151.8B | $196.9B | AstraZeneca PLC |
| 2023 | $107.9B | $198.1B | AstraZeneca PLC |
| 2022 | $126.1B | $195.3B | AstraZeneca PLC |
| 2021 | $105.1B | $163.9B | AstraZeneca PLC |
| 2020 | $85.2B | $136.9B | AstraZeneca PLC |
| 2019 | $109.2B | $132.8B | AstraZeneca PLC |
| 2018 | $75.9B | $97.9B | AstraZeneca PLC |
| 2017 | $89.0B | $85.9B | RTX Corporation |
| 2016 | $74.7B | $64.5B | RTX Corporation |
| 2015 | $63.8B | $76.6B | AstraZeneca PLC |
| 2014 | $74.5B | $76.2B | AstraZeneca PLC |
| 2013 | $72.2B | $61.7B | RTX Corporation |
| 2012 | $50.9B | $46.3B | RTX Corporation |
| 2011 | $44.2B | $42.7B | RTX Corporation |
| 2010 | $46.5B | $40.3B | RTX Corporation |
| 2009 | $40.0B | $38.9B | RTX Corporation |
| 2008 | $30.1B | $32.3B | AstraZeneca PLC |
| 2007 | $42.0B | $32.3B | RTX Corporation |
| 2006 | $33.8B | $39.1B | AstraZeneca PLC |
| 2005 | $29.7B | $34.5B | AstraZeneca PLC |
| 2004 | $27.0B | $25.2B | RTX Corporation |
| 2003 | $24.4B | $32.9B | AstraZeneca PLC |
| 2002 | $15.7B | $23.4B | AstraZeneca PLC |
| 2001 | $16.1B | $30.5B | AstraZeneca PLC |
| 2000 | $19.4B | $33.1B | AstraZeneca PLC |
| 1999 | $15.8B | $25.7B | AstraZeneca PLC |
| 1998 | $13.1B | $27.2B | AstraZeneca PLC |
| 1997 | $8.6B | $21.4B | AstraZeneca PLC |
| 1996 | $7.7B | $16.3B | AstraZeneca PLC |
| 1995 | $5.4B | $11.1B | AstraZeneca PLC |
| 1994 | $3.5B | $7.5B | AstraZeneca PLC |